Mon, Oct 05, 2026 - Page 9
5773 indexed SquawkNews stories from this UTC day. Showing 961-1080.
L
NeoGenomics Names Warren Stone CEO Effective Jan. 4
Warren Stone, currently President and Chief Operating Officer, will become the new CEO of NeoGenomics on January 4.
EQUITY | Oct 05, 2026, 08:13 PM UTC
L
Korro Bio doses first cohort in Phase 1/2 ANCHOR trial
Korro Bio has dosed the first cohort in its Phase 1/2 ANCHOR trial of KRRO-121, administering a 2 mg/kg single dose to healthy volunteers.
EQUITY | Oct 05, 2026, 08:13 PM UTC
L
Silver Bow grants 3,648 RSUs to Travis Naugle
Silver Bow Mining Corp. granted 3,648 restricted stock units to Travis Naugle. The RSUs vest upon a change in control, a sale of most assets, or his departure from the board.
EQUITY | Oct 05, 2026, 08:13 PM UTC
H
US Stocks Gain as Big Tech Shares Rally
US stock indices closed higher on Monday as a rally in heavyweight technology shares outweighed concerns over still-elevated oil prices and bond yields. The S&P 500 rose 0.7%, the Nasdaq 100 gained 0.9% to close at a rec
EARNINGS | Oct 05, 2026, 08:13 PM UTC
L
Neogenomics names Warren Stone CEO, Tony Zook becomes Executive Chairman
Neogenomics appointed Warren Stone as Chief Executive Officer effective January 4, 2027. Tony Zook will transition to Executive Chairman on the same date. Lynn Tetrault will step down as Board Chair, and Michael Kelly be
EQUITY | Oct 05, 2026, 08:13 PM UTC
L
OFA Group Names Eugene M. Johnston CFO, Ernest Yeung Resigns
OFA Group has appointed Eugene M. Johnston as its new Chief Financial Officer, effective October 1, 2026. This change follows the resignation of Ernest Yeung from the CFO position, effective September 30, 2026.
EQUITY | Oct 05, 2026, 08:13 PM UTC
L
Valuence Merger Corp. I extends SPAC combination deadline to Nov. 3, 2026
Valuence Merger Corp. I approved a one-month extension of its business combination deadline to November 3, 2026 and funded the trust with $13,897.14.
EQUITY | Oct 05, 2026, 08:13 PM UTC
L
Campbell's Prices $300M Junior Subordinated Notes
Campbell Soup Co. has priced a $300 million offering of 8.500% fixed-to-fixed reset rate junior subordinated notes due 2057.
RATES | Oct 05, 2026, 08:13 PM UTC
L
UBS Cuts Orion Price Target to $6.50
UBS has reduced its price target on Orion to $6.50 per share from $8.00.
EQUITY | Oct 05, 2026, 08:13 PM UTC
L
Aethlon Medical shareholders reject proposal to authorize 20 million preferred shares
Aethlon Medical shareholders rejected a proposal to authorize 20,000,000 shares of preferred stock. The company filed an amended 8-K to correct a prior disclosure, stating the proposal failed to pass as only 204,122 shar
EQUITY | Oct 05, 2026, 08:13 PM UTC
M
US Stocks Climb on AI Optimism Amid Rising Bond Yields
US stocks advanced as enthusiasm for the artificial-intelligence boom counterbalanced increasing global bond yields. The Dow Jones Industrial Average gained 90.94 points (0.18%) to 51267.90, the S&P 500 added 51.23 point
EQUITY | Oct 05, 2026, 08:12 PM UTC
M
Nasdaq hits 23rd record high of 2024; S&P 500, Dow also rise
The Nasdaq Composite closed at its 23rd record high of the year, boosted by tech giants like Nvidia and Microsoft. The S&P 500 and Dow also finished higher, despite a rise in U.S. 10-year Treasury yields to their highest
EQUITY | Oct 05, 2026, 08:12 PM UTC
L
Grindr director George Raymond Zage III sells $7.04 million in shares
Grindr director George Raymond Zage III sold 500,000 shares on Oct. 1-2, 2026, under a 10b5-1 plan. The sales were priced between USD 13.65 and USD 15.65 per share. His directly held stake fell to 7,127,743 shares.
EQUITY | Oct 05, 2026, 08:12 PM UTC
L
UBS Maintained Methanex at Buy, Raised Price Target
UBS maintained its buy rating on Methanex (MX) and raised its price target to $74.00 per share from $71.00.
EQUITY | Oct 05, 2026, 08:12 PM UTC
L
DoorDash International COO Keith Yandell disposes of 2,183 common shares worth $400,994.27
DoorDash International COO Keith Yandell sold 2,183 shares of Class A common stock on Oct. 1, 2026. Sale price USD 183.69 per share. * Beneficial ownership stood at 118,505 shares following the transaction. Disclaimer: T
FX | Oct 05, 2026, 08:12 PM UTC
L
Zimmer Biomet files Form 3 for Gary Craig Campbell, President Americas
Zimmer Biomet filed a Form 3 for Gary Craig Campbell, President, Americas, reporting 6,515 restricted stock units plus stock options for 12,053 shares. Disclaimer: This news brief was created by Public Technologies (PUBT
EQUITY | Oct 05, 2026, 08:12 PM UTC
L
Independent Bank Corp. schedules third-quarter 2026 earnings release for Oct. 15
Independent Bank Corp. schedules its third-quarter 2026 earnings release for Oct. 15, 2026, after market close, with a conference call set for Oct. 16.
EQUITY | Oct 05, 2026, 08:12 PM UTC
M
Broadstone Net Lease schedules Q3 2026 earnings release and call
Broadstone Net Lease will release its financial and operating results for the quarter ended September 30, 2026, after market close on Wednesday, October 28, 2026. The company will host its earnings conference call and au
EQUITY | Oct 05, 2026, 08:12 PM UTC
L
Adeia renews multi-year IP license with Charter Communications' Spectrum
Adeia has renewed its multi-year intellectual property license agreement with Charter Communications' Spectrum brand, extending coverage to Spectrum's broadband and mobility businesses. This renewal continues a licensing
EQUITY | Oct 05, 2026, 08:12 PM UTC
M
Granite Ridge Resources schedules Q3 2026 earnings conference call
Granite Ridge Resources, Inc. will report its third quarter 2026 financial and operating results after market close on Thursday, November 5, 2026, and will host a conference call the following day at 10:00 a.m. CT.
EQUITY | Oct 05, 2026, 08:12 PM UTC
L
Eledon to present kidney transplant trial outcomes for tegoprubart at ASN Kidney Week
Eledon Pharmaceuticals Inc. will present new patient-reported outcomes from its Phase 2 BESTOW kidney-transplant trial of tegoprubart versus tacrolimus on Oct. 23, 2026, at ASN Kidney Week in Denver.
EQUITY | Oct 05, 2026, 08:12 PM UTC
L
Alamar Biosciences names former GRAIL CEO Bob Ragusa to board
Alamar Biosciences appointed former GRAIL CEO Bob Ragusa to its board of directors. Ragusa brings more than two decades in genomics, diagnostics, and biotech; previously served as Illumina’s chief operations officer. Joh
EQUITY | Oct 05, 2026, 08:12 PM UTC
L
No Saudi confirmation of Houthi statement
No Saudi confirmation of Houthi statement
NEWS | Oct 05, 2026, 08:12 PM UTC
L
New Zealand National Party support at weakest level since 2020: poll
New Zealand's ruling National Party has fallen to 25.9% support, its weakest result since the 2020 election, while the opposition Greens climbed to 14.8%, an RNZ-Reid Research poll showed on Tuesday. Labour also slipped
EQUITY | Oct 05, 2026, 08:12 PM UTC
L
Aligos Therapeutics to present hep B data at AASLD Liver Meeting
Aligos Therapeutics will present clinical data for pevifoscorvir sodium in chronic hepatitis B, showing immune effects and viral suppression, at AASLD's The Liver Meeting 2026. Updates also cover ALG-170675 for hepatitis
EQUITY | Oct 05, 2026, 08:12 PM UTC
M
Olin schedules Q3 2026 earnings call for Oct 30
Olin Corp has scheduled its third-quarter 2026 earnings conference call for Oct. 30, 2026, at 10:00 a.m. ET. The company will release its third-quarter 2026 results, including financial statements and segment data, after
EQUITY | Oct 05, 2026, 08:12 PM UTC
L
Iron Mountain EVP Greg McIntosh sells 5,000 shares worth $553,600
Iron Mountain EVP, Chief Commercial Officer Greg W. McIntosh sold 5,000 common shares on Oct. 1, 2026 at $110.72. His stake fell to 70,634 shares.
EQUITY | Oct 05, 2026, 08:12 PM UTC
M
BWXT, Prodigy Clean Energy to develop transportable nuclear power plant
BWX Technologies will work with Prodigy Clean Energy on deploying BANR microreactors for a transportable nuclear power plant project in New Brunswick. Prodigy selected BWXT’s BANR technology for an Indigenous-led pilot T
MACRO | Oct 05, 2026, 08:12 PM UTC
L
Campbell's prices $300 million junior subordinated notes
Campbell's priced a USD 300 million offering of 8.500% Fixed-to-Fixed Reset Rate Junior Subordinated Notes due April 5, 2057. The notes were priced Oct. 1, 2026 and issuance closed Oct. 5, 2026.
RATES | Oct 05, 2026, 08:11 PM UTC
L
Merlin to Participate in Investor Conferences
Merlin, Inc. announced that its management is scheduled to participate in three investor conferences in the fourth quarter of 2026.
EQUITY | Oct 05, 2026, 08:11 PM UTC
L
Bakkafrost corrects Q3 fish meal sales to 1,200 tonnes
Bakkafrost corrected its Q3 trading update, revising total fish meal sold to 1,200 tonnes from 0. Q3 fish oil sales were 0 tonnes. The Q3 report remains scheduled for release on November 2.
EQUITY | Oct 05, 2026, 08:11 PM UTC
L
Twist Bioscience Insiders Sold Shares Worth Over $9.1M
Dennis Cho, Senior Vice President, Chief Legal Officer & Corporate Secretary at Twist Bioscience, sold 9,514 shares of common stock at $188.884 per share, totaling $1,797,042. He directly owns 63,789 shares following the
EQUITY | Oct 05, 2026, 08:11 PM UTC
M
AbbVie cuts Q3 EPS forecast to $3.73-$3.77 on $216 mln expense
AbbVie cut its Q3 adjusted diluted EPS guidance to USD 3.73-3.77 from USD 3.84-3.88, citing acquired IPR&D and milestones expense of USD 216 million, equal to a USD 0.11 per-share hit. Full-year guidance was also lowered
EARNINGS | Oct 05, 2026, 08:11 PM UTC
L
Amazon Stores CEO Herrington sells 1,000 shares for $251,500
Amazon.com officer Douglas J. Herrington, CEO Worldwide Amazon Stores, sold 1,000 common shares on Oct. 1, 2026, at $251.5 per share. His directly held stake fell to 474,681 shares.
EQUITY | Oct 05, 2026, 08:11 PM UTC
L
Ichor COO Bruce Ragsdale sells $239,093 of common shares
Bruce Ragsdale, chief operating officer at Ichor Holdings, sold 1,580 shares at $62.48 and 2,149 shares at $65.47 on Oct. 1-2, 2026.
EQUITY | Oct 05, 2026, 08:11 PM UTC
M
Mattel urged to explore sale by Ariel Investments
Ariel Investments, holder of a 5.4% stake in Mattel, is urging the toymaker to explore strategic alternatives, including a potential sale. The investment firm believes Mattel shares are significantly undervalued.
MNA | Oct 05, 2026, 08:11 PM UTC
L
Castle Biosciences: COO Oelschlager disposes of 4,153 shares for $148,434
Castle Biosciences COO Kristen Oelschlager exercised stock options for 4,153 shares at $3.38 and sold them the same day at weighted-average prices of $35.75-$36.38, totaling $148,434. Her directly held stake fell to 13,3
EQUITY | Oct 05, 2026, 08:11 PM UTC
M
HelloFresh SE: Active Ownership Opportunities SCS acquires shares
Active Ownership Opportunities SCS acquired shares in HelloFresh SE for 2.34 EUR on October 2, 2026.
EQUITY | Oct 05, 2026, 08:11 PM UTC
M
Starbucks Sued Over Allegedly Misleading 'Sugar-Free' Drink Labels
Starbucks faces a class-action lawsuit accusing it of mislabeling eight "Protein Beverages" as "Sugar-Free" when they contain 13-21 grams of sugar, violating federal regulations. Consumers allege this misled them about c
REGULATION | Oct 05, 2026, 08:11 PM UTC
H
ICE canola futures rise on soyoil strength
(All figures in Canadian dollars unless noted) WINNIPEG, Manitoba, Oct 5 (Reuters) — ICE canola futures settled higher on Monday as Chicago soy oil gained. November canola futures rose 0.44% or $3.90 to $819.40 per metri
ENERGY | Oct 05, 2026, 08:11 PM UTC
L
Neptune Insurance: Matthew Paul Duffy sells USD 1.1 million common shares
President and Chief Risk Officer Matthew Paul Duffy sold 39,737 Class A common shares of Neptune Insurance Holdings on Oct. 2 for USD 27.646 and USD 28.4804 per share. His directly held stake decreased to 2,005,631 share
EQUITY | Oct 05, 2026, 08:11 PM UTC
L
Silver Bow Mining grants director Travis Naugle 3,648 RSUs
Silver Bow Mining granted director Travis Naugle 3,648 restricted stock units on Sept. 30, 2026. The RSUs vest on a change in control, a sale of majority assets, or Naugle’s departure from the board.
EQUITY | Oct 05, 2026, 08:11 PM UTC
L
Lucid Group delivers 3,806 vehicles in Q3 2026, exceeding production
Lucid produced 2,954 vehicles in the third quarter ended Sept. 30, 2026, and delivered 3,806, reducing inventory. Deliveries exceeded production as part of an operating reset targeting $1.4 billion in cash flow improveme
EQUITY | Oct 05, 2026, 08:10 PM UTC
L
Granite Ridge Resources schedules third-quarter earnings call
Granite Ridge Resources will report third-quarter 2026 financial and operating results on Nov. 5, 2026, with management discussing the results on a webcast and conference call on Nov. 6, 2026.
EQUITY | Oct 05, 2026, 08:10 PM UTC
L
Huntsman Price Target Cut to $9.00 From $10.00 by UBS
EQUITY | Oct 05, 2026, 08:10 PM UTC
L
Valuence Merger Corp. I extends business combination deadline to Nov. 3, 2026
Valuence Merger Corp. I has extended the deadline for its initial business combination to November 3, 2026. This is the sixth of ten possible one-month extensions. An additional $13,897.14 was deposited into the trust ac
EQUITY | Oct 05, 2026, 08:10 PM UTC
M
Korro Bio (KRRO.O) dosed first healthy volunteers in Phase 1/2 ANCHOR KRRO-121
Korro Bio dosed the first healthy-volunteer cohort in its Phase 1/2 ANCHOR trial of KRRO-121 for hyperammonemia; single 2 mg/kg dose, with interim readout expected in 2H 2027 and patient dosing expected in H1 2027.
EQUITY | Oct 05, 2026, 08:10 PM UTC
L
OFA Group names Eugene M. Johnston CFO, replacing Ernest Yeung
OFA Group CFO Ernest Yeung resigned effective Sept. 30, 2026, citing personal reasons. Eugene M. Johnston appointed CFO effective Oct. 1, 2026.
EQUITY | Oct 05, 2026, 08:10 PM UTC
L
Eastman Chemical Maintained at Buy by UBS
UBS maintained its Buy rating on Eastman Chemical, setting a price target of $77.00 per share, down from $92.00.
EQUITY | Oct 05, 2026, 08:10 PM UTC
H
Euro Drops to 16-Month Low on French Fiscal Strain, Spanish Election
The euro fell to a more than 16-month low against the dollar on Monday amid growing concerns about France's fiscal position and Spain's announcement of a snap election. Worries about increased French government spending
FX | Oct 05, 2026, 08:10 PM UTC
M
Lucid schedules Q3 2026 earnings call for Nov. 9
Lucid schedules its Q3 2026 earnings call for Nov. 9, 2026, at 2:30 p.m. PT (5:30 p.m. ET).
EQUITY | Oct 05, 2026, 08:10 PM UTC
L
Tech Rally Lifts Stocks Despite Elevated Oil and Yields — US Market Wrap
Tech Rally Lifts Stocks Despite Elevated Oil and Yields — US Market Wrap
COMMODITIES | Oct 05, 2026, 08:10 PM UTC
L
NeoGenomics names Warren Stone CEO effective Jan. 4, 2027
NeoGenomics has appointed President and COO Warren Stone as CEO and a board member, effective Jan. 4, 2027. Stone, 54, previously held senior roles at Ortho Clinical Diagnostics and MilliporeSigma/Merck KGaA.
EQUITY | Oct 05, 2026, 08:10 PM UTC
M
Nasdaq Composite Rises 286.45 Points
The Nasdaq Composite index increased by 286.45 points, a 1.05% gain.
EQUITY | Oct 05, 2026, 08:10 PM UTC
L
DJIA Rises 90.94 Points (0.18%)
The Dow Jones Industrial Average increased by 90.94 points, or 0.18%.
EQUITY | Oct 05, 2026, 08:10 PM UTC
L
Saudi-Led Coalition: Naval Forces Carried Out Military Operation In Yemen’s Al Hodeidah Governorate
Saudi-Led Coalition: Naval Forces Carried Out Military Operation In Yemen’s Al Hodeidah Governorate
NEWS | Oct 05, 2026, 08:10 PM UTC
M
S&P 500 Rises 51.23 Points
The S&P 500 index increased by 51.23 points, representing a 0.66% gain.
EQUITY | Oct 05, 2026, 08:10 PM UTC
M
Broadstone Net Lease Schedules Q3 2026 Earnings Release
Broadstone Net Lease, Inc. announced it will release its financial and operating results for the quarter ended September 30, 2026, after the market closes on Wednesday, October 28, 2026.
EQUITY | Oct 05, 2026, 08:10 PM UTC
H
CLARITY Act Failure Spurs New CFTC Crypto Rules, Chairman Selig Says It's 'Just The Beginning'
The Commodity Futures Trading Commission is moving ahead with its own first round of crypto market-structure rules after Congress failed to advance the CLARITY Act. Chairman Michael Selig noted that the existing statutor
LIVE | Oct 05, 2026, 08:10 PM UTC
L
Chemours Maintained at Neutral by UBS
UBS maintained its Neutral rating on Chemours.
EQUITY | Oct 05, 2026, 08:09 PM UTC
L
Mulvihill Split Preferred Share ETF Sets $0.11667 Monthly Distribution
Mulvihill Split Preferred Share ETF declared a monthly cash distribution of $0.11667 per share, payable Nov 6, 2026, to shareholders of record on Oct 30, 2026.
EQUITY | Oct 05, 2026, 08:09 PM UTC
L
ORIC Pharmaceuticals Partners With Cancer Research UK on ORIC-259
ORIC Pharmaceuticals announced a partnership with Cancer Research UK to advance ORIC-259. Cancer Research UK will fund and execute studies and Phase 1/2 trials for the drug. ORIC retains an option to reacquire rights aft
EQUITY | Oct 05, 2026, 08:09 PM UTC
L
Mulvihill Premium Yield Declares $0.07 Monthly Distribution
Mulvihill Premium Yield declared a $0.07 per unit monthly cash distribution for its ETF Class, payable Nov. 6, 2026, to unitholders of record on Oct. 30, 2026.
EQUITY | Oct 05, 2026, 08:09 PM UTC
L
Mulvihill Split Capital Share ETF Sets $0.25 Monthly Distribution
Mulvihill Split Capital Share ETF declared a $0.25 per-share monthly cash distribution, payable Nov 6, 2026, to shareholders of record on Oct 30, 2026.
EQUITY | Oct 05, 2026, 08:09 PM UTC
L
Mulvihill Enhanced Split Preferred Share ETF Sets $0.08333 Monthly Distribution
The Mulvihill Enhanced Split Preferred Share ETF (SPFD) has declared a monthly cash distribution of $0.08333 per unit. This distribution is payable on November 6, 2026, to unit holders of record as of October 30, 2026.
EQUITY | Oct 05, 2026, 08:09 PM UTC
L
Equillium Cleared in Australia for EQ504 Phase 1 Study
Equillium has received clearance in Australia to initiate a randomized, double-blind, placebo-controlled Phase 1 study of EQ504 in healthy subjects. Dosing is expected by early November 2026, with topline proof-of-mechan
EQUITY | Oct 05, 2026, 08:08 PM UTC
L
Korro Bio doses first cohort in Phase 1/2 trial for KRRO-121
Korro Bio has begun dosing the first cohort in its ANCHOR Phase 1/2 program for KRRO-121, an RNA-editing oligonucleotide for hyperammonemia. SAD/MAD studies are underway in healthy volunteers in Australia.
EQUITY | Oct 05, 2026, 08:08 PM UTC
L
Neostellar Capital Preliminary Q3 NAV At $12.25—$12.75
Neostellar Capital has issued a preliminary, unaudited net asset value (NAV) estimate for the third quarter of 2026, setting it between $12.25 and $12.75 per share. This is a decrease from the $13.44 NAV recorded as of J
EARNINGS | Oct 05, 2026, 08:08 PM UTC
L
Adeia Renews Multi-Year IP License With Spectrum
Adeia has renewed a multi-year intellectual property license agreement with Charter Communications' Spectrum, extending coverage to Spectrum's broadband and mobility businesses in addition to its existing pay-TV and vide
EQUITY | Oct 05, 2026, 08:08 PM UTC
L
Mulvihill Split Preferred Share ETF Declares Monthly Distribution
The Mulvihill Split Preferred Share ETF has declared a monthly cash distribution of $0.11667 per share, payable on November 6, 2026, to shareholders of record on October 30, 2026.
EQUITY | Oct 05, 2026, 08:08 PM UTC
L
Mulvihill Canadian Bank ETF Declares Monthly Distribution
The Mulvihill Canadian Bank ETF has declared a monthly cash distribution of $0.05 per share. This distribution will be paid on November 6, 2026, to shareholders recorded on October 30, 2026.
EQUITY | Oct 05, 2026, 08:08 PM UTC
L
Mulvihill Premium Yield Declares Monthly ETF Class Distribution
Mulvihill Premium Yield has declared a monthly cash distribution of $0.07 per unit for its ETF Class. The distribution is payable on November 6, 2026, to unitholders of record on October 30, 2026.
EQUITY | Oct 05, 2026, 08:08 PM UTC
L
Panoro Minerals Ltd. (PML) Secures 5-Year Access for Cotabambas Drilling
Panoro Minerals Ltd. signed a 5-year surface access agreement with the Cochapata community, enabling ~10,000 m of drilling at Cotabambas’ North Pit to expand and upgrade high-grade resources, with resource update targete
EQUITY | Oct 05, 2026, 08:08 PM UTC
L
Mulvihill Enhanced Split Preferred Share ETF Declares Monthly Distribution
Mulvihill Enhanced Split Preferred Share ETF has declared a monthly cash distribution of $0.08333 per unit, payable on November 6, 2026, to unitholders of record on October 30, 2026.
EQUITY | Oct 05, 2026, 08:08 PM UTC
H
CTW (CTW) Sets Oct. 15 Release for FY26 Results, Webinar Oct. 16
CTW will release financial results for the six months and fiscal year ended July 31, 2026 after market close on Oct. 15, and will host an earnings webinar at 8:30am ET on Oct. 16.Material DetailsContext by AI AnalystThis
EARNINGS | Oct 05, 2026, 08:08 PM UTC
L
Standard BioTools to Sell Microfluidics Unit to ARCHIMED
Standard BioTools Inc. agreed to sell its Microfluidics business to ARCHIMED. The closing is expected in approximately 30 days, subject to customary conditions.
EQUITY | Oct 05, 2026, 08:08 PM UTC
L
Alamar Biosciences Appoints Former Grail CEO Bob Ragusa to Board
Alamar Biosciences has appointed Bob Ragusa, former CEO of GRAIL, to its board of directors. The company also named John Brottem as general counsel and Amelia Merrill as chief people officer. This leadership expansion is
EQUITY | Oct 05, 2026, 08:08 PM UTC
L
Premium Income Corp. Declares Monthly Distribution
Premium Income Corporation has declared monthly distributions payable on October 30, 2026, to shareholders of record on October 15, 2026.
EQUITY | Oct 05, 2026, 08:08 PM UTC
L
Eledon to present at ASN Kidney Week 2026 meeting
Eledon Pharmaceuticals said an oral presentation will be featured at the American Society of Nephrology Kidney Week 2026 Annual Meeting in Denver from October 21–25, 2026.
EQUITY | Oct 05, 2026, 08:08 PM UTC
L
Mulvihill Split Capital Share ETF Declares Monthly Distribution
Mulvihill Split Capital Share ETF has declared a monthly cash distribution of $0.25 per share, payable on November 6, 2026, to shareholders of record on October 30, 2026.
EQUITY | Oct 05, 2026, 08:08 PM UTC
L
BioMarin names Cara Bauer chief people officer from Oct. 5, 2026
BioMarin Pharmaceutical Inc. appointed Cara Bauer as executive vice president and chief people officer, effective October 5, 2026. Bauer previously served as chief human resources officer at Kyverna Therapeutics and held
EQUITY | Oct 05, 2026, 08:08 PM UTC
L
ORIC Pharma, Cancer Research UK to Advance CIP2A Therapy
ORIC Pharmaceuticals announced an agreement with Cancer Research UK to advance its potential first-in-class CIP2A-targeted therapy, ORIC-259, into clinical development. Cancer Research UK will fund, sponsor, design, and
EQUITY | Oct 05, 2026, 08:08 PM UTC
L
Leonardo DRS Completes Training and Delivery of Thermal Weapon Sights for Australian Army
Leonardo DRS, Inc. has completed the final training and delivery of its Improved Night/Day Observation Device (INOD) Block III thermal weapon sights to the Australian Army, enhancing their sniper capabilities.
EQUITY | Oct 05, 2026, 08:08 PM UTC
L
Cabaletta Bio Reports Inducement Grants Under Nasdaq Listing Rule
Cabaletta Bio announced the grant of inducement equity awards to new employees under Nasdaq Listing Rule 5635(c)(4).
EQUITY | Oct 05, 2026, 08:08 PM UTC
L
Acuity: SVP Global Head HR Sara Dadyar files initial Form 3
Sara Dadyar, SVP and global head of HR at Acuity, filed an initial Form 3 disclosing 1,687 shares of common stock.
EQUITY | Oct 05, 2026, 08:08 PM UTC
L
Mulvihill Canadian Bank Enhanced Yield ETF Declares Monthly Distribution
Mulvihill Canadian Bank Enhanced Yield ETF has declared a monthly cash distribution of $0.12 per unit, payable on November 6, 2026, to unitholders of record on October 30, 2026.
EQUITY | Oct 05, 2026, 08:08 PM UTC
L
Polar Power Rejects Solidion Asset Offer
Polar Power, Inc. rejected an all-cash offer from Solidion for its company assets, stating it remains focused on maximizing shareholder value and evaluating credible strategic opportunities.
EQUITY | Oct 05, 2026, 08:08 PM UTC
L
CTW updates financial calendar for fiscal 2026 results release, earnings webinar
CTW will release results for the six months and fiscal year ended July 31, 2026 on Oct. 15, 2026, after market close. Management will host an earnings webinar on Oct. 16, 2026 at 8:30 a.m. ET.
EQUITY | Oct 05, 2026, 08:08 PM UTC
L
Hercules Capital prices upsized $400 million 6.70% notes due 2029
Hercules Capital priced an upsized USD 400 million offering of 6.70% notes due October 2029. The unsecured notes will pay interest semiannually, with maturity set for Oct. 8, 2029. Proceeds are earmarked for debt repayme
RATES | Oct 05, 2026, 08:08 PM UTC
L
BridgeBio and Community Partners launch nationwide ATTR-CM education effort
BridgeBio Pharma and Community Partners plan a nationwide community education initiative ahead of World Amyloidosis Day, with a YouTube premiere on Oct. 6 featuring Sway Calloway and Howard “H” White.
EQUITY | Oct 05, 2026, 08:08 PM UTC
L
Vir Biotechnology to present expanded Phase 2 SOLSTICE data on elebsiran-tobevibart combo in hepatitis delta at
Vir Biotechnology will present expanded Phase 2 SOLSTICE data on its elebsiran with tobevibart combination therapy for chronic hepatitis delta at AASLD The Liver Meeting 2026 in Denver. The update through Week 96 will fo
EQUITY | Oct 05, 2026, 08:08 PM UTC
L
Sprout Social schedules third-quarter results for Nov. 3
Sprout Social will report third-quarter 2026 results on Nov. 3, 2026, following the market close. Management will discuss results on a webcast conference call at 3:30 p.m. CT on Nov. 3, 2026.
EQUITY | Oct 05, 2026, 08:08 PM UTC
L
Equillium Receives Australian Regulatory Clearance for EQ504 Clinical Trial
Equillium has received Australian regulatory clearance to initiate a first-in-human clinical trial for its EQ504 drug. The randomized, double-blind, placebo-controlled study will evaluate the safety, tolerability, pharma
EQUITY | Oct 05, 2026, 08:08 PM UTC
L
Alamar Biosciences Names Former Grail CEO Bob Ragusa to Board, Expands Leadership
Alamar Biosciences, Inc. (NASDAQ:ALMR) has appointed former Grail CEO Bob Ragusa to its board of directors. The company also expanded its leadership team with the appointments of John Brottem as general counsel and Ameli
EQUITY | Oct 05, 2026, 08:08 PM UTC
L
Standard BioTools to sell microfluidics business to ARCHIMED
Standard BioTools entered into a definitive agreement to sell its Microfluidics business to ARCHIMED.
MNA | Oct 05, 2026, 08:08 PM UTC
L
Japan Post Holdings sells 11,900 Aflac shares for $1.31 million
Japan Post Holdings sold 11,900 Aflac common shares on Oct. 1, 2026, reducing its indirect beneficial ownership to 50,433,390 shares.
EQUITY | Oct 05, 2026, 08:08 PM UTC
M
Polar Power Rejects Acquisition Proposal From Solidion
The Board of Directors at Polar Power has rejected an all-cash proposal from Solidion that aimed to acquire the company's assets.
EQUITY | Oct 05, 2026, 08:08 PM UTC
L
Korro Bio Doses First Patient in KRRO-121 Trial
Korro Bio, Inc. has dosed the first patient in its Phase 1/2 clinical trial for KRRO-121, a novel therapy utilizing the company's OPERA® platform.
EQUITY | Oct 05, 2026, 08:08 PM UTC
L
Neostellar Capital Corp. Announces Third Quarter 2026 Preliminary Investment Portfolio Update
Net Asset Value Expected to be $12.25 to $12.75 Per ShareNEW YORK, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Neostellar Capital Corp. (“Neostellar Capital”, the “Company”, “we”, “us”, and “our”) (Nasdaq: NSLR) today provided a p
EQUITY | Oct 05, 2026, 08:08 PM UTC
L
Aligos Therapeutics has five abstracts accepted for The Liver Meeting
Aligos Therapeutics, Inc. announced that five abstracts have been accepted for presentation at The Liver Meeting 2026.
EQUITY | Oct 05, 2026, 08:08 PM UTC
M
Northwest Bancshares schedules Q3 earnings call for Oct. 27
Northwest Bancshares Inc. scheduled its third-quarter earnings call for Oct. 27, 2026, at 9:00 a.m. ET. The company plans to release its third-quarter results after market close on Oct. 26, 2026.
EQUITY | Oct 05, 2026, 08:08 PM UTC
L
Twist Bioscience CEO Emily Leproust sells $8.77 million in shares
Twist Bioscience CEO Emily M. Leproust sold 46,391 common shares on Oct. 1-2, at prices of USD 200 and USD 188.884 per share. Her directly held stake fell to 567,308 shares.
EQUITY | Oct 05, 2026, 08:08 PM UTC
L
Adeia Renews IP License Agreement With Spectrum
Adeia Inc. has renewed its intellectual property license agreement with Spectrum, extending their long-standing relationship.
EQUITY | Oct 05, 2026, 08:08 PM UTC
L
Cabot Corp Maintained Neutral by UBS
EQUITY | Oct 05, 2026, 08:08 PM UTC
L
Anavex Life Sciences names Gautam Patel as director
Gautam Patel was appointed to the board of Anavex Life Sciences, effective Sept. 24, 2026, according to a Form 3 filing dated Oct. 5, 2026.
EQUITY | Oct 05, 2026, 08:08 PM UTC
M
Standard BioTools to sell its Microfluidics business to ARCHIMED, close in about 30 days
Standard BioTools agreed to sell its Microfluidics business to healthcare-focused investor ARCHIMED. Closing is targeted in about 30 days, subject to customary closing conditions, with Microfluidics operations remaining
MNA | Oct 05, 2026, 08:08 PM UTC
L
JPMorgan Spots Value in American Express Stock
JPMorgan has included American Express (AXP) in its October value-stock picks, noting an 18% year-to-date slide in its shares. American Express shares were trading near $302.70, down about 0.1% as of 11:24 a.m. ET on Oct
EQUITY | Oct 05, 2026, 08:08 PM UTC
M
Trinity Industries to contest UTLX antidumping petition over Mexico tank car imports
Trinity Industries faces an antidumping and countervailing duty petition filed by UTLX at the US Commerce Department and US ITC. The petition targets imports of railway tank cars from Mexico, raising the risk of duties t
REGULATION | Oct 05, 2026, 08:08 PM UTC
L
Equillium secures Australian TGA clearance for EQ504 Phase 1 trial
Equillium Inc. received Australian TGA clearance to begin a first-in-human Phase 1 trial of EQ504, with first dosing expected by early November 2026 and topline data projected about six months later.
EQUITY | Oct 05, 2026, 08:08 PM UTC
L
Hertz schedules third-quarter 2026 results release and earnings call
Hertz Global Holdings Inc. will report third-quarter 2026 results at 8:00 a.m. ET on Nov. 5, 2026, with an earnings call scheduled for 9:00 a.m. ET the same day.
EQUITY | Oct 05, 2026, 08:08 PM UTC
L
Panoro Minerals Ltd. Signs 5-Year Access Agreement for Cotabambas Project
Panoro Minerals Ltd. announced the signing of a five-year agreement with the community of Cochapata for its Cotabambas Project.
EQUITY | Oct 05, 2026, 08:08 PM UTC
M
Public Storage sets Q3 earnings for Oct. 26
Public Storage will release its third-quarter 2026 earnings after market close on October 26, 2026, followed by a conference call on October 27, 2026.
EQUITY | Oct 05, 2026, 08:07 PM UTC
M
Universal Health Services sets Q3 2026 earnings for Oct. 26
Universal Health Services will release its third-quarter 2026 results after market close on Oct. 26, 2026. The company has scheduled an investor conference call for Oct. 27, 2026, at 9:30 a.m. ET.
EQUITY | Oct 05, 2026, 08:07 PM UTC
M
Neostellar Capital publishes Q3 2026 preliminary update; estimates Sept. 30 NAV at $12.25-$12.75
Neostellar Capital estimated NAV of $12.25-$12.75 per share as of Sept. 30, 2026, and reported liquid assets of about $42.2 million.
EARNINGS | Oct 05, 2026, 08:07 PM UTC
L
Aviat Networks signs India manufacturing deal with Dixon
Aviat Networks has signed a license-to-manufacture agreement with Dixon Electro Appliances for WTM 4000 microwave products in India, with Dixon set to manufacture and sell approved products to select Indian telecom opera
EQUITY | Oct 05, 2026, 08:07 PM UTC
L
NanoXplore unit VoltaXplore names Jonathan Blanshay to advisory board
VoltaXplore, a wholly owned NanoXplore unit, formed an advisory board to guide its battery manufacturing strategy, naming Galvion founder and CEO Jonathan Blanshay as its first member.
EQUITY | Oct 05, 2026, 08:07 PM UTC
M
Netstreit to release Q3 earnings Oct. 21, 2026
Netstreit Corp. will report its third-quarter 2026 financial results on October 21, 2026. A conference call is scheduled for October 22, 2026, at 11:00 a.m. ET.
EQUITY | Oct 05, 2026, 08:07 PM UTC
M
Cuba and US keep communication channels open but no negotiations: diplomat
Cuba's top diplomat in Washington said on Monday that contacts with the US continue but are not formal negotiations, and that Cuba has increased defense preparations in case of US military action.
GEOPOLITICS | Oct 05, 2026, 08:07 PM UTC
M
agilon health schedules Q3 2026 results for Nov. 4
agilon health Inc. will release its third-quarter 2026 financial results and host a conference call on Nov. 4, 2026.
EQUITY | Oct 05, 2026, 08:07 PM UTC
M
Ampera submits regulatory plan to U.S. Nuclear Regulatory Commission
Advanced nuclear company Ampera has submitted a comprehensive Regulatory Engagement Plan to the U.S. Nuclear Regulatory Commission as part of the pre-application phase of the licensing process, anticipating submission of
REGULATION | Oct 05, 2026, 08:07 PM UTC